Safety and Effectiveness of Natalizumab Post-Marketing Surveillance: The 3rd Year Interim Results

YOKOYAMA Kazumasa; SATO Ryusuke; MAKIOKA Daiki; IIZUKA Yukihiko; HIRAMATSU Katsutoshi; LING Yan; TORII Shinichi; SAITA Takahiko; SAITA Takahiko

Art

J-GLOBAL ID：201802250562096074 Reference number：18A1694002

Safety and Effectiveness of Natalizumab Post-Marketing Surveillance: The 3rd Year Interim Results

ナタリズマブの安全性と有効性の市販後調査 3年目の暫定的結果

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=18A1694002&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1694002&from=J-GLOBAL&jstjournalNo=L3036C") }}

Author (9)： , , , , , , , ,
Material：
Volume： 23 Issue： 1 Page： 132 Publication year： 2018
JST Material Number： L3036C ISSN： 0918-936X Document type： Proceedings
Article type：会議録記事 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1694002&from=J-GLOBAL&jstjournalNo=L3036C") }}

Drug therapy(=pharmacotherapy)for nervous system diseases , Treatment for immunologic diseases,allergic diseases.

, ,

Return to Previous Page